Free Trial
LON:BNR

Burning Rock Biotech (BNR) Share Price, News & Analysis

GBX 3.56
-1.10 (-23.56%)
(As of 09/13/2024)

About Burning Rock Biotech Stock (LON:BNR)

Key Stats

Today's Range
3.56
3.56
50-Day Range
3.56
6.58
52-Week Range
3.56
11.50
Volume
200 shs
Average Volume
75 shs
Market Capitalization
£3.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Blenheim Natural Resources Plc invests in companies or assets in the natural resources and agribusiness sectors. It engages in establishing strategic and portfolio investments in listed and unlisted shares, as well as in projects in the natural resource sector covering the mining, oil and gas, and agricultural sectors. The company was formerly known as Coburg Group plc and changed its name to Blenheim Natural Resources Plc in September 2015. Blenheim Natural Resources Plc was incorporated in 1994 and is based in London, the United Kingdom.

Receive BNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter.

BNR Stock News Headlines

Burning Rock Biotech Ltd ADR BNR
We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
See More Headlines

BNR Stock Analysis - Frequently Asked Questions

Burning Rock Biotech's stock was trading at GBX 0.77 on January 1st, 2024. Since then, BNR shares have increased by 363.2% and is now trading at GBX 3.56.
View the best growth stocks for 2024 here
.

Shares of BNR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Burning Rock Biotech investors own include Clearside Biomedical (CLSD), Joint (JYNT), AbbVie (ABBV), Acasti Pharma (ACST), ADMA Biologics (ADMA), Adamis Pharmaceuticals (ADMP) and Akebia Therapeutics (AKBA).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic Imaging Centers
Sub-Industry
Healthcare
CIK
N/A
Fax
N/A
Employees
1,390
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
£3.77 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (LON:BNR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners